Home
About Us
Activities
Achievements
Awards
Publications
Photo Gallery
Contact Us
 
List of Publications

Publications of Padmashree Dr. C. P. Thakur

  1. C. P. Thakur, Tetany in kala-azar patients treated with paromomycin, Indian J Med Res 127; 505-509 2008.
  2. C. P. Thakur, A new strategy for elimination of kala-azar from rural Bihar, Indian J Med Res 126; 447-451: 2007.
  3. C. P. Thakur, A. Kumar, G. Mitra, S. Thakur & M. Thakur, Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine, Indian J Med Res 126; 75-75:2007.
  4. Sundar S, Jha TK, Thakur CP, Sinha PK & Bhattacharya SK Injectable paromomycin for visceral leishmaniasis in India. N Eng J of Med 2007; 356: 2571-81.
  5. S K Bhattachary, P K Sinha, CP Thakur, TK Jha, K Pandey, V R Das, N Kumar, C Lal, N Verma, VP Singh, A Ranjan, RB Verma, G Anders, H Sindermann, NK Ganguly; Phase-4 trial of miltefosine for the treatment of Indian Visceral Leishmaniasis. JID 2007; 196:591-598.
  6. Thakur CP & S. Narayan. A comparative evaluation of amphotericin B and sodium antimony gluconate, as first line drug in the treatment of Indian visceral leishmaniasis. Annals of Tropical Medicine and Parasitology. 98(2);129-138:2004.
  7. Thakur CP, Narayan S. & A. Ranjan. Epidemiological, clinical & pharmaco-logical study of antimony resistant visceral leishmaniasis in Bihar, India . Indian Journal of Medical Research, 120;166-172: 2004.
  8. Thakur CP, Mitra DK, Narayan S. Skewing of cytokine profile towards Th2 direction in drug unresponsiveness kala-azar patients Trans R Soc Trop Med Hyg. 97; 409-412: 2004.
  9. Thakur CP, Narayan S, Ranjan A. Kala-Azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing? J Acquir Immune Defic Syndr. 32(5);572-73:2003.
  10. Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R. Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg. 2002 Feb;66(2):143-6.
  11. Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R.Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg. 2002 Feb;66(2):143-6.
  12. Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med. 2002 Nov 28;347(22):1739-46.
  13. Thakur CP, Ahmed S. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India. Indian J Med Res. 2001 Jan;113:14-8.
  14. Thakur CP. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study. Int J Antimicrob Agents. 2001 Jan;17(1):67-70.
  15. Thakur CP, Dedet JP, Narain S, Pratlong F. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Trans R Soc Trop Med Hyg. 2001 Mar-Apr;95(2):187-9.
  16. Thakur C.P. Socio-economics of visceral leishmaniasis in Bihar (India). Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):156-7.
  17. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Zaniewski AE, Houlihan HH, Olliaro P. A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2000 Jul-Aug;94(4):429-31.
  18. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Messick C, Olliaro P. Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg. 2000 Jul-Aug;94(4):432-3.
  19. Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):696-7.
  20. Bodhe PV, Kotwani RN, Kirodian BG, Pathare AV, Pandey AK, Thakur CP, Kshirsagar NA. Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):314-8.
  1. Thakur CP, Singh RK, Hassan SM, Kumar R, Narain S, Kumar A. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):319-23.
  2. Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med. 1999 Dec 9;341(24):1795-800.
  3. Thakur CP. Sodium antimony gluconate, amphotericin, and myocardial damage. Lancet. 1998 Jun 27;351(9120):1928-9.
  4. Thakur CP, Sinha GP, Pandey AK, Kumar N, Kumar P, Hassan SM, Narain S, Roy RK. Do the diminishing efficacy and increasing toxicity of sodium  stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Ann Trop Med Parasitol. 1998 Jul;92(5):561-9.
  5. Thakur CP, Kumar P, Kumar N, Singh GN, Singh AK, Narain S. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar. J Assoc Physicians India. 1998 Sep;46(9):779-83.
  6. Berman JD, Badaro R, Thakur CP, Wasunna KM, Behbehani K, Davidson R, Kuzoe F, Pang L, Weerasuriya K, Bryceson AD. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ. 1998;76(1):25-32.
  7. Thakur CP, Narain S, Kumar N, Hassan SM, Jha DK, Kumar A. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol. 1997 Sep;91(6):611-6.
  8. Thakur CP. A comparison of intercostal and abdominal routes of splenic aspiration and bone marrow aspiration in the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):668-70.
  9. Thakur CP, Sinha GP, Pandey AK. Comparison of regimens of amphotericin B deoxycholate in kala-azar. Indian J Med Res. 1996 May;103:259-63.
  10. Thakur CP, Pandey AK, Sinha GP, Roy S, Behbehani K, Olliaro P. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):319-22.
  11. Thakur CP. Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration. Natl Med J India. 1995 Jan-Feb;8(1):13-4.
  12. Thakur CP, Bhowmick S, Dolfi L, Olliaro P. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):219-23.
  13. Thakur CP. Controversy in the regimens of treatment with amphotericin B in resistant cases of kala-azar. J Assoc Physicians India. 1995 Nov;43(11):813-4.
  14. Gokhale PC, Kshirsagar NA, Khan MU, Pandya SK, Meisheri YV, Thakur CP, Choudhary CB. Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B. Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):228.
  15. Thakur CP, Sinha GP, Barat D, Singh RK. Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? Ann Trop Med Parasitol. 1994 Aug;88(4):365-70.
  16. Thakur CP. Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar. Trans R Soc Trop Med Hyg. 1994 Nov-Dec;88(6):698-9.
  17. Thakur CP, Frances Sister, Therese Sister, Victoria Sister, Puspa Sister. A kala-azar control programme for remote tribal communities. World Health Forum. 1994;15(3):245-7.
  18. Thakur CP, Sinha GP, Pandey AK, Barat D, Singh RK. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison. Bull World Health Organ. 1994;72(6):931-6.
  19. Thakur CP, Sinha GP, Sharma V, Pandey AK, Sinha PK, Barat D. Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life. Indian J Pediatr. 1993 Jan-Feb;60(1):29-36.
  20. Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK. Amphotericin B in resistant kala-azar in Bihar. Natl Med J India. 1993 Mar-Apr;6(2):57-60.
  21. Thakur CP. Lymphatic leishmaniasis in India. J Assoc Physicians India. 1993 Apr;41(4):227-8.
  22. Thakur CP, Sinha GP, Sharma V, Pandey AK, Kumar M, Verma BB. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar. Indian J Med Res. 1993 Jul;97:170-5.
  23. Thakur CP, Sinha GP, Sharma V, Barat D. The treatment of kala-azar during pregnancy. Natl Med J India. 1993 Nov-Dec;6(6):263-5.
  24. Thakur CP, Kumar M.  Observations on the effect of verapamil with sodium stibogluconate in kala azar. Trop Geogr Med. 1992 Jan;44(1-2):15-8.
  1. Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol. 1992 Aug;86(4):355-9.
  1. Thakur CP. Treatment of kala-azar in India. Natl Med J India. 1992 Sep-Oct;5(5):203-5.
  1. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, Kumar M, Verma BB. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):615-6.
  1. Thakur CP, Kumar M, Pandey AK. Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate. Indian J Med Res. 1991 Mar;93:103-10.
  1. Thakur CP, Kumar M, Pandey AK. Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. Am J Trop Med Hyg. 1991 Oct;45(4):435-41.
  1. Thakur CP, Kumar K. Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis. Indian J Med Res. 1990 Mar;91:144-8.
  1. Thakur CP, Sinha PK. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar. J Trop Med Hyg. 1989 Dec;92(6):383-5.
  1. Thakur CP, Kumar M, Kumar P, Mishra BN, Pandey AK. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study. Br Med J (Clin Res Ed). 1988 Jun 4;296(6636):1557-61.
  1. Pandey AK, Kumar M, Thakur CP. ECG changes in prolonged treatment of kala-azar with antimony compounds. J Assoc Physicians India. 1988 Jun;36(6):398-9.
  1. Thakur CP, Thakur B, Singh S, Sinha PK, Sinha SK. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol. 1988 Nov;21(2):167-75.
  1. Thakur CP. Chemotherapy of leishmaniasis in India. Indian J Pediatr. 1987 Jan-Feb;54(1):7-10.
  1. Thakur CP, Thakur B, Singh S, Kumar B. Relation between full moon & medicolegal deaths. Indian J Med Res. 1987 Mar;85:316-20.
  1. Thakur CP, Anand MP, Shahi MP. Cold weather and myocardial infarction. Int J Cardiol. 1987 Jul;16(1):19-25.
  1. Thakur CP. Treatment for visceral leishmaniasis. J Assoc Physicians India. 1987 Sep;35(9):641-3. Review.
  1. Thakur CP, Kumar K, Sinha PK, Mishra BN, Pandey AK. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate. Br Med J (Clin Res Ed). 1987 Oct 10;295(6603):886-7.
  1. Thakur CP. Harmful effect of high stibogluconate treatment of kala-azar in India. Trans R Soc Trop Med Hyg. 1986;80(4):672-3.
  1. Thakur CP. Treatment of visceral leishmaniasis in Bihar. Trop Doct. 1986 Oct;16(4):146-7.
  1. Thakur CP. Treatment of visceral leishmaniasis. J Assoc Physicians India. 1985 May;33(5):379-80.
  1. Thakur CP, Anand MP, Shahi MP. Effect of variation of temperature on the incidence of stroke. J Assoc Physicians India. 1986 Dec;34(12):855-7.
  1. Thakur CP, Kumar SK. Effect of pheno borbitone. J. Indian Med. Assoc. 1986.
  1. Thakur CP. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg. 1984;78(3):391-8.
  1. Thakur CP, Mandal K. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits. Indian J Med Res. 1984 Jan; 79:142-6.
  1. Thakur CP, Kumar M, Singh SK, Sharma D, Prasad US, Singh RS, Dhawan PS, Achari V. Comparison of regimens of treatment with sodium stibogluconate in kala-azar. Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):895-7.
  1. Thakur CP, Sharma D. Full moon and crime. Br Med J (Clin Res Ed). 1984 Dec 22-29;289(6460):1789-91.
  1. Thakur CP, Sharma RN. Epidemic dropsy with unusual features. Trop Doct. 1983 Apr;13(2):55-6.
  1. Thakur CP. Leishman-Donovan bodies in the duodenal mucosa of a child with kala-azar. Br Med J (Clin Res Ed). 1983 Oct 22;287(6400):1221.
  1. Thakur CP, Kumar A. Electrolyte excretion pattern of normal and hypertensive. Indian Heart J. 1983 Nov-Dec;35(6):329-32.
  1. Thakur CP & Sharma RN. Epidemic Dropsy with unusual features. Trop. Doctor 1983; 13: 55-56.
  1. Kumar M, Thakur CP. Relation of serum calcium with serum proteins in hypo-proteinaemic states. J Assoc Physicians India. 1982 Mar;30(3):135-7.
  1. Thakur CP, Ali M. Egg protein and defatted soya protein on cholesterol induced hypercholesterolaemia and atherosclerosis in rabbits. Indian J Med Res. 1982 Jun;75:862-7.
  1. Thakur CP, Sharma RN, Akhtar HS. Prohibition and alcohol intoxication. Br J Addict. 1982 Jun;77(2):197-204.
  1. Thakur CP, Sharma RN. Prohibition & Alcohol intoxication. Brit. Journal of Addication 1982;77 :197-204.
  1. Thakur CP, Jha AN. Influence of milk, yoghurt and calcium on cholesterol-induced atherosclerosis in rabbits. Atherosclerosis. 1981 May;39(2):211-5.
  1. Thakur CP, Kumar SC. Influence of mustard oil on cholesterol-induced atherosclerosis in albino rabbits. Atherosclerosis. 1981 Jun;39(3):437-8.
  1. Thakur CP, Kumar M, Pathak PK. Kala-azar hits again. J Trop Med Hyg. 1981 Dec;84(6):271-6.
  1. Thakur CP,. Introduction of Allergy. IMA College of General Practione, New Delhi 1981: 2-5.
  1. Thakur CP, Sharma RN, Akhtar HS. Full moon and poisoning. Br Med J. 1980 Dec 20-27;281(6256):1684.
  1. Thakur CP, Kumar Mahendra. Trial of Sovanj in Urinary Tract, Gastro- intestinal & Upper respiratory tract infections. Patna L. Med. 1980;34 (ii) 341-42.
  1. Thakur CP & Kumar Mahendra. Serum lactic dehydro genase activity as a diagnostic aid in leukaemia. Patna J. Ned. 1980.
  1. Thakur CP, Jha RR.. A case of Trico-bezoar. Patna J. Med. 1980.  
  1. Thakur CP, Sinha KP, Gupta AK, Kumar SC. Study of the outbreak of kala-azar epidemic in Bihar. J Assoc Physicians India. 1978 Jun;26(6):511-8.
  1. Dubey M, Thakur CP. Influence of linseed oil on cholesterol-induced atherosclerosis in rabbits. Atherosclerosis. 1979 Jan;32(1):81-6.
  1. Thakur CP.  Study of 250 cases of tropical eosinophilia. Indian J Chest Dis. 1971 Oct;13(4):140-7.
  1. Thakur CP.Mannitol induced diuresis in a case of anuria of more than 48 hours in a patient with unilateral kidney. Patna J. Med. 154, March 1970.
  1. Thakur CP.  Studies of mortality from rheumatic heart disease. Indian Heart J. 1969 Jan;21(1):61-8.
  1. Thakur CP.  Dehydroemetine oral tablets in amoebiasis. J Assoc Physicians India. 1969 Feb;17(2):93-5.
  1. Thakur CP. Observation on a recent outbreak of epidemic dropsy. J. Assoc. Phy. India. 1968; 50: 203-207.
  1. Thakur CP, Kalita GN, Das M. An unusual case of angina pectoris with diffuse arterial calcification in a young male. Indian Heart J. 1967 Jul;19(3):253-7.
  1. Srivastava DK, Thakur CP, Das M. ABO-blood groups in relation to ischaemic heart disease. Indian Heart J. 1966 Apr;18(2):140-9.
  1. Thakur CP, Das M. Evaluation of Routine use of corticosteroids in the treatment of enteric fever. J. Ass. Phy. India. 1966;14: 429-432.
  1. Thakur CP, Vishwakarma AK, Prasad Swaminandan. Weber’s syndromein cast of tuberculous meningitis. Antiseptic 1966;63:384-86.
  1. Thakur CP. . Successful conservative management of spontaneous intraperitoneal rupture of amebic liver abscess. A case report. Indian J Med Sci. 1965 Oct;19(10):766-7.
  1. Thakur CP. . The syndrome of ptosis, generalized muscular weakness and marked fasciculations of calf muscles due to insect bite. J Indian Med Assoc. 1965 Nov 1;45(9):503-4.
  1. Thakur CP, Srivastava DK. The diagnosis of pyramidal tract lesion in the absence of Babinski Singh. J. Assoc. Phy. Ind. 1965; 13: 205-207.
  1. Thakur CP, Sarangi BP. Unsuspected a typical amoebic liver absess. Atiseptic 1965; 19: 661-64.
  1. Thakur CP, Kumar P, Kumar N, Singh GN, Singh AK, Narain S. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar. J Assoc Physicians India. 1998 Sep;46(9):779-83.
  1. Thakur CP, Singh SK, Sinha RP. Missed cases of local tetanus. J Indian Med Assoc. 1986 Nov;84(11):354-6.
  1. Thakur CP. Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia. 1985 Mar 15;41(3):423-4.
  1. Sunder S, Jha TK, Thakur CP, Sinha PK, and Bhattacharya SK; Injectable Paromomycin for visceral leishmaniasis in India. N Eng J Med. 2007; 356:2571-2581.
  2. C. P. Thakur, A Kumar, G Mitra, S Thakur, M Thakur, Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine, Indian J Med Res 126, July 2007, pp 73-75.
  3.  C. P. Thakur, A new strategy for elimination of kala-azar from rural Bihar, Indian J Med Res 126, November 2007, pp447-451. 

 

Home | About Us | Activities | Publications |Contact Us
Best viewed using IE6 or above with 1024 X 768 resolution. | Webmail